Plata Mauricio, Robledo Daniela, Bravo-Balado Alejandra, Castaño Juan Carlos, Osorio Catalina, Salazar Milton, Velásquez Juan Guillermo, Trujillo Carlos Gustavo, Caicedo Juan Ignacio, Cataño Juan Guillermo
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, D.C., Colombia.
Department of Urology, Clínica Universitaria CES, Universidad CES and Pontificia Universidad Bolivariana, Medellín, Colombia.
Int Urogynecol J. 2018 Sep;29(9):1371-1378. doi: 10.1007/s00192-018-3568-8. Epub 2018 Mar 3.
We report our experience with the Remeex system™ in women with recurrent stress urinary incontinence (SUI) or intrinsic sphincter deficiency (ISD).
A multicenter retrospective study was conducted in women who underwent an adjustable sling procedure between 2011 and 2016. We used urodynamic studies (UDS) preoperatively and the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and cough stress test (CST) pre- and postoperatively. Primary outcomes were subjective (no leakage reported by the patient) and objective (no leakage during CST) cure and improvement rates (reduction of ≥4 points in ICIQ-SF). Descriptive and inferential statistics were employed.
A total of 50 patients were included. Mean age was 62 years (SD ± 11.35). Median follow-up was 19.5 months [interquartile range (IQR) 12.95-41.38]. Urinary incontinence (UI) was described as moderate and severe by 8 (16%) and 42 (84%) patients, respectively, and 25 (50%) had stress-predominant mixed urinary incontinence (MUI). Objective and subjective cure rates were 90% and 48%, respectively, while 82% of patients achieved improvement. Impact of UI on quality of life (QoL) improved from 10 (IQR 9-10) to 2 (IQR 0-5) (p < 0.0001). Clavien-Dindo II complications occurred in 14 (28%) patients, and one (2%) had IIIa. Tape erosion occurred in one (2%) patient, and five (10%) required readjustments. Logistic regression identified MUI [odds ratio (OR) 3.3, 95% confidence interval (CI) 1.02-10.89] and vaginal atrophy (OR 4.2, 95% CI 1.06-16.03) as predictors of low subjective cure rate.
Adjustable slings represent a valuable and safe option in the management of recurrent SUI or ISD, with improvement in QoL. Results should be carefully interpreted due to our small sample and retrospective design.
我们报告了在复发性压力性尿失禁(SUI)或固有括约肌缺陷(ISD)女性患者中使用Remeex系统™的经验。
对2011年至2016年间接受可调节吊带手术的女性患者进行了一项多中心回顾性研究。我们在术前使用尿动力学研究(UDS),并在术前和术后使用国际尿失禁咨询问卷简表(ICIQ-SF)和咳嗽压力试验(CST)。主要结局指标为主观(患者报告无漏尿)和客观(CST期间无漏尿)治愈率及改善率(ICIQ-SF降低≥4分)。采用描述性和推断性统计方法。
共纳入50例患者。平均年龄为62岁(标准差±11.35)。中位随访时间为19.5个月[四分位间距(IQR)12.95 - 41.38]。分别有8例(16%)和42例(84%)患者将尿失禁(UI)描述为中度和重度,25例(50%)有以压力性为主的混合性尿失禁(MUI)。客观治愈率和主观治愈率分别为90%和48%,82%的患者病情得到改善。UI对生活质量(QoL)的影响从10(IQR 9 - 10)改善至2(IQR 0 - 5)(p < 0.0001)。14例(28%)患者发生Clavien-Dindo II级并发症,1例(2%)发生IIIa级。1例(2%)患者出现吊带侵蚀,5例(10%)需要重新调整。逻辑回归分析确定MUI[比值比(OR)3.3,95%置信区间(CI)1.02 - 10.89]和阴道萎缩(OR 4.2,95% CI 1.06 - 16.03)是主观治愈率低的预测因素。
可调节吊带是复发性SUI或ISD治疗中一种有价值且安全的选择,可改善生活质量。由于我们的样本量小且为回顾性设计,结果应谨慎解读。